We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $225B
1-Year Est. Return 49.49%
This Fund
S&P 500
This Quarter Est. Return
+6.85%
1 Year Est. Return
+49.49%
3 Year Est. Return
+172.58%
5 Year Est. Return
+223.9%
10 Year Est. Return
+876%
AUM
$171B
AUM Growth
+$12.1B
Cap. Flow
+$7.2B
Cap. Flow %
4.22%
Top 10 Hldgs %
21.93%
Holding
2,081
New
254
Increased
812
Reduced
646
Closed
273

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$4.07B
2
AAPL icon
Apple
AAPL
+$2.9B
3
ORCL icon
Oracle
ORCL
+$1.31B
4
NFLX icon
Netflix
NFLX
+$1.24B
5
MRK icon
Merck
MRK
+$823M

Sector Composition

Rank Sector Weight
1 Technology 32.98%
2 Consumer Discretionary 12.91%
3 Healthcare 12.83%
4 Financials 9.9%
5 Materials 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPNT icon
1651
SiriusPoint
SPNT
$2.7B
$606K ﹤0.01%
+27,672
New +$555K
SSYS icon
1652
Stratasys
SSYS
$779M
$604K ﹤0.01%
69,539
-3,044
-4% -$30.2K
SHIP icon
1653
Seanergy Maritime Holdings
SHIP
$360M
$603K ﹤0.01%
65,283
-18,971
-23% -$172K
CXM icon
1654
Sprinklr
CXM
$1.65B
$597K ﹤0.01%
+76,749
New +$584K
PNTG icon
1655
Pennant Group
PNTG
$1.35B
$589K ﹤0.01%
+20,920
New +$556K
BSVN icon
1656
Bank7 Corp
BSVN
$499M
$587K ﹤0.01%
14,316
TEX icon
1657
Terex
TEX
$7.57B
$573K ﹤0.01%
+10,728
New +$542K
CAH icon
1658
Cardinal Health
CAH
$53.8B
$571K ﹤0.01%
2,777
-188,802
-99% -$35.5M
EFOR
1659
Everforth Inc
EFOR
$1.37B
$564K ﹤0.01%
+11,706
New +$540K
PETS icon
1660
PetMed Express
PETS
$43.4M
$561K ﹤0.01%
175,233
VWO icon
1661
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$559K ﹤0.01%
10,404
-21,113
-67% -$1.15M
STLN
1662
Starling Oncology, Inc. Common Stock
STLN
$638M
$554K ﹤0.01%
+155,724
New +$578K
MSB
1663
Mesabi Trust
MSB
$305M
$551K ﹤0.01%
14,297
-2,393
-14% -$81K
ERO icon
1664
Ero Copper
ERO
$3.58B
$550K ﹤0.01%
+19,445
New +$453K
HWBK icon
1665
Hawthorn Bancshares
HWBK
$277M
$544K ﹤0.01%
15,606
TX icon
1666
Ternium
TX
$10.7B
$541K ﹤0.01%
+14,161
New +$520K
CERS icon
1667
Cerus
CERS
$572M
$527K ﹤0.01%
+255,961
New +$444K
FRBA icon
1668
First Bank
FRBA
$471M
$524K ﹤0.01%
+31,813
New +$509K
FLWS icon
1669
1-800-Flowers.com
FLWS
$261M
$523K ﹤0.01%
133,045
-130,015
-49% -$510K
KEQU icon
1670
Kewaunee Scientific
KEQU
$105M
$522K ﹤0.01%
13,960
-4,178
-23% -$170K
NDAQ icon
1671
Nasdaq
NDAQ
$54.6B
$519K ﹤0.01%
5,340
-278,552
-98% -$25M
BCRX icon
1672
BioCryst Pharmaceuticals
BCRX
$2.51B
$517K ﹤0.01%
66,244
-5,159,742
-99% -$37.3M
MG icon
1673
Mistras Group
MG
$584M
$516K ﹤0.01%
40,796
-41,134
-50% -$464K
OVLY icon
1674
Oak Valley Bancorp
OVLY
$288M
$515K ﹤0.01%
17,129
TMP icon
1675
Tompkins Financial
TMP
$1.45B
$511K ﹤0.01%
+7,045
New +$483K

Similar funds

Arrowstreet Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Arrowstreet Capital held 2,081 positions worth $171B, up 7.7% from $159B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Arrowstreet Capital deployed $7.2B of net new capital in Q4 2025, opening 254 new positions and adding to 812 existing holdings. Its largest new stake was Teck Resources: 3,550,320 shares worth $170M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $4.07B trimmed.

  • Arrowstreet Capital's largest Q4 2025 buy was Teck Resources: 3,550,320 shares worth $170M.
  • Arrowstreet Capital added most to Alphabet (Google) Class C in Q4 2025, an estimated $1.34B increase.
  • Arrowstreet Capital's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $4.07B.
  • Arrowstreet Capital fully exited Oracle in Q4 2025, selling an estimated $1.31B.
  • Arrowstreet Capital's ten largest holdings make up 22% of its $171B portfolio in Q4 2025.
  • Arrowstreet Capital opened 254 new positions and closed 273 in Q4 2025.
  • Arrowstreet Capital's portfolio value rose 7.7% quarter-over-quarter to $171B.

Based on Arrowstreet Capital's 13F filing for Q4 2025, filed 13 Feb 2026.